Voyager Therapeutics (VYGR) Capital Expenditures Growth (3y) (2017 - 2026)
Voyager Therapeutics (VYGR) Capital Expenditures Growth (3y) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | -12.25% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 46.88% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 8.97% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Voyager Therapeutics | 183.84 Mn | 42.36 Mn | - | -69.81% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -69.81% |
| Dec 31, 2025 | -54.02% |
| Sep 30, 2025 | -47.68% |
| Jun 30, 2025 | 126.43% |
| Mar 31, 2025 | 42.37% |
| Dec 31, 2024 | 1.32% |
| Sep 30, 2024 | 33.60% |
| Jun 30, 2024 | 138.85% |
| Mar 31, 2024 | -65.80% |
| Dec 31, 2023 | 135.75% |
| Sep 30, 2023 | 236.24% |
| Jun 30, 2023 | -86.90% |
| Mar 31, 2023 | 110.87% |
| Dec 31, 2022 | -49.64% |
| Sep 30, 2022 | 53.95% |
| Jun 30, 2022 | -153.94% |
| Mar 31, 2022 | 193.70% |
| Dec 31, 2021 | -66.94% |
| Jun 30, 2021 | 13.56% |
| Mar 31, 2021 | 146.62% |